Výsledky vyhledávání - Ho‐June Lee
- Zobrazuji výsledky 1 - 8 z 8
-
1
-
2
Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M Autor Ho‐June Lee, Gabriele Schaefer, Timothy P. Heffron, Lily Shao, Xiaofen Ye, Steve Sideris, Shiva Malek, Emily Chan, Mark Merchant, Hank La, Savita Ubhayakar, Robert L. Yauch, Valentina Pirazzoli, Katerina Politi, Jeff Settleman
Vydáno 2012Artigo -
3
Essential Roles of Atg5 and FADD in Autophagic Cell Death Autor Jong-Ok Pyo, Mi‐Hee Jang, Yun‐Kyung Kwon, Ho-June Lee, Joon-Il Jun, Ha‐Na Woo, Dong-Hyung Cho, BoYoun Choi, Heuiran Lee, Joo-Hang Kim, Noboru Mizushima, Yoshinori Oshumi, Yong‐Keun Jung
Vydáno 2005Artigo -
4
The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth Autor Hyun‐Joo Kim, Ho-June Lee, Yumin Oh, Seon-Guk Choi, Se-Hoon Hong, Hyo-Jin Kim, Song-Yi Lee, Ji-Woo Choi, Deog Su Hwang, Key-Sun Kim, Hyo Joon Kim, Jianke Zhang, Hyun-Jo Youn, Dong‐Young Noh, Yong‐Keun Jung
Vydáno 2014Artigo -
5
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways Autor Trang H. Pham, Thijs J. Hagenbeek, Ho-June Lee, Jason Li, Christopher M. Rose, Eva Lin, Mamie Yu, Scott E. Martin, Robert Piskol, Jennifer A. Lacap, Deepak Sampath, Victoria C. Pham, Zora Modrušan, Jennie R. Lill, Christiaan Klijn, Shiva Malek, Matthew T. Chang, Anwesha Dey
Vydáno 2020Artigo -
6
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors Autor Thijs J. Hagenbeek, Joshua D. Webster, Noelyn M. Kljavin, Matthew T. Chang, Trang Pham, Ho-June Lee, Christiaan Klijn, Allen G. Cai, Klára Tótpál, Buvana Ravishankar, Nai-Ying Yang, Da-Hye Lee, Kevin B. Walsh, Georgia Hatzivassiliou, Cecile C. de la Cruz, Stephen E. Gould, Xiumin Wu, Wyne P. Lee, Shuqun Yang, Zhixiang Zhang, Qingyang Gu, Qunsheng Ji, Erica L. Jackson, Dae‐Sik Lim, Anwesha Dey
Vydáno 2018Artigo -
7
Immunopathogenesis of ANCA-Associated Vasculitis Autor Andreas Kronbichler, Keum Hwa Lee, Sara Denicolò, Daeun Choi, Hyojeong Lee, Dong-Hyun Ahn, Kang Hyun Kim, Ji-Han Lee, Hyungtae Kim, M. Hwang, Sun Wook Jung, Changjun Lee, Ho‐June Lee, Haejune Sung, Dongkyu Lee, Jae-Hyuk Hwang, Sohee Kim, Injae Hwang, Do Young Kim, Hyung Jun Kim, Geonjae Cho, Yunryoung Cho, Dong‐Il Kim, Min Choi, Junhye Park, Junseong Park, Kalthoum Tizaoui, Han Li, Lee Smith, Ai Koyanagi, Louis Jacob, Philipp Gauckler, Jae Il Shin
Vydáno 2020Revisão -
8
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance Autor Thijs J. Hagenbeek, Jason R. Zbieg, Marc Hafner, Rana Mroue, Jennifer A. Lacap, Nicole M. Sodir, Cameron L. Noland, Shervin Afghani, Ayush Kishore, Kamakoti P. Bhat, Xiaosai Yao, Stephen D. Schmidt, Saundra Clausen, Micah Steffek, Wendy Lee, Paul Beroza, Scott E. Martin, Eva Lin, Rina Fong, Paola Di Lello, Marta H. Kubala, Michelle N.-Y. Yang, Jeffrey Lau, Emily Chan, Alfonso Arrazate, Le An, Elizabeth Levy, Maria Lorenzo, Ho-June Lee, Trang H. Pham, Zora Modrušan, Richard Zang, Yi‐Chen Chen, Michał Kabza, Musaddeque Ahmed, Jason Li, Matthew T. Chang, Danilo Maddalo, Marie Evangelista, Xin Ye, James J. Crawford, Anwesha Dey
Vydáno 2023Artigo
Vyhledávací nástroje:
Související témata
Biology
Cell biology
Genetics
Cancer research
Hippo signaling pathway
Kinase
Apoptosis
Cancer
Caspase
Effector
FADD
Gene
Immunology
KRAS
Medicine
Programmed cell death
Receptor
Signal transduction
Transcription factor
ATG5
Activator (genetics)
Adenylate kinase
Allosteric regulation
Anti-neutrophil cytoplasmic antibody
Autocrine signalling
Autophagy
Biochemistry
Cancer cell
Carcinogenesis
Cell culture